Wakizaka Y, Miki T, Rao A, Wang X, Goller A, Demetris A
Xenotransplantation. 2011; 4(4):262-266.
PMID: 21318077
PMC: 3035846.
DOI: 10.1111/j.1399-3089.1997.tb00191.x.
Colleoni M, Audisio R, de Braud F, Fazio N, Martinelli G, Goldhirsch A
Drugs. 1998; 55(3):367-82.
PMID: 9530543
DOI: 10.2165/00003495-199855030-00004.
Dubois J, Garel L, Patriquin H, Paradis K, Forget S, Filiatrault D
Pediatr Radiol. 1996; 26(12):845-51.
PMID: 8929295
DOI: 10.1007/BF03178035.
Van Thiel D, Carr B, Iwatsuki S, Selby R, Fung J, Starzl T
J Surg Oncol Suppl. 1993; 3:78-82.
PMID: 8389178
PMC: 2977953.
DOI: 10.1002/jso.2930530522.
Van Thiel D, Gavaler J, TARTER R, Starzl T
Semin Liver Dis. 1985; 5(4):318-24.
PMID: 3909424
PMC: 2974338.
DOI: 10.1055/s-2008-1040627.
Liver transplantation: current concepts.
Wall W
CMAJ. 1988; 139(1):21-8.
PMID: 3289710
PMC: 1267982.
Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.
Kvittingen E, Jellum E, Stokke O, Flatmark A, Bergan A, Sodal G
J Inherit Metab Dis. 1986; 9(2):216-24.
PMID: 3091928
DOI: 10.1007/BF01799465.
Liver transplantation (1).
Starzl T, Demetris A, Van Thiel D
N Engl J Med. 1989; 321(15):1014-22.
PMID: 2674716
PMC: 3091023.
DOI: 10.1056/NEJM198910123211505.
Liver transplantation for hereditary tyrosinemia in the presence of hepatocellular carcinoma.
Esquivel C, Mieles L, Marino I, Todo S, Makowka L, Ambrosino G
Transplant Proc. 1989; 21(1 Pt 2):2445-6.
PMID: 2540570
PMC: 2903894.
Liver transplantation for hereditary tyrosinemia: the Quebec experience.
Paradis K, Weber A, Seidman E, Larochelle J, Garel L, Lenaerts C
Am J Hum Genet. 1990; 47(2):338-42.
PMID: 2378360
PMC: 1683709.
Visceral pathology of hereditary tyrosinemia type I.
Russo P, ORegan S
Am J Hum Genet. 1990; 47(2):317-24.
PMID: 2378357
PMC: 1683701.
Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1.
Bain M, Purkiss P, Jones M, Bingham P, Stacey T, Chalmers R
Eur J Pediatr. 1990; 149(9):637-9.
PMID: 2373116
DOI: 10.1007/BF02034752.
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.
Linton M, Gish R, HUBL S, Butler E, Esquivel C, Bry W
J Clin Invest. 1991; 88(1):270-81.
PMID: 2056122
PMC: 296029.
DOI: 10.1172/JCI115288.
Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15.
Phaneuf D, Labelle Y, Berube D, Arden K, Cavenee W, Gagne R
Am J Hum Genet. 1991; 48(3):525-35.
PMID: 1998338
PMC: 1682993.
Liver transplantation in two children with tyrosinaemia type I: biochemical aspects.
Riudor E, Ribes A, Lloret J, Friden J, Holme E, Jakobs C
J Inherit Metab Dis. 1991; 14(3):281-4.
PMID: 1770775
DOI: 10.1007/BF01811682.
Treatment of inherited metabolic disorders by liver transplantation.
Burdelski M, Rodeck B, Latta A, Latta K, BRODEHL J, Ringe B
J Inherit Metab Dis. 1991; 14(4):604-18.
PMID: 1749225
DOI: 10.1007/BF01797930.
Update of pediatric liver transplantation.
Alonso E, Whitington P
Eur J Pediatr. 1992; 151 Suppl 1:S23-31.
PMID: 1345099
DOI: 10.1007/BF02125799.
